(New standalone addition in 2024)
| Pathogen | |----------| | Streptococcus pneumoniae (penicillin-non-susceptible) | | Haemophilus influenzae (ampicillin-resistant) | | Shigella spp. (fluoroquinolone-resistant) |
These pathogens cause increasingly difficult-to-treat infections that are often found in community settings. World Health Organization (WHO) WHO bacterial priority pathogens list, 2024 who priority pathogens list for r&d of new antibiotics
The list serves as a roadmap for scientists, investors, and policymakers to focus on bacteria for which new treatments are most desperately needed. 1. Critical Priority
For the full 2024 report, search: "WHO bacterial priority pathogens list 2024" on the WHO official website. (New standalone addition in 2024) | Pathogen |
The is a strategic global catalog designed to steer the research and development (R&D) of new antibiotics toward the most dangerous drug-resistant bacteria.
| Pathogen | Key Resistance | |----------|----------------| | Enterococcus faecium | Vancomycin-resistant (VRE) | | Staphylococcus aureus | Methicillin-resistant (MRSA), Vancomycin-intermediate/resistant (VISA/VRSA) | | Helicobacter pylori | Clarithromycin-resistant | | Campylobacter jejuni | Fluoroquinolone-resistant | | Salmonella Typhi | Fluoroquinolone-resistant | | Neisseria gonorrhoeae | 3rd-gen cephalosporin-resistant, fluoroquinolone-resistant | 🦠 The 2024 Priority Categories
(Highest public health threat)
Published by the , this list categorizes antibiotic-resistant bacteria into tiers to guide and prioritize research & development (R&D) of new antimicrobials. It was first released in 2017 and updated in 2024.
Updated in , the list categorizes 24 antibiotic-resistant pathogens into three priority tiers— Critical , High , and Medium —based on their public health impact and the status of current treatment pipelines. 🦠 The 2024 Priority Categories